GlassScriptPhysician profile
Lauren Knapp
NPI 1275929408
$1,279.89
in general payments reported to CMS, 2019-2025
31 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $41.28 · 2022: $365 · 2023: $277 · 2024: $284 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $264.39 | 2020-2024 | |
| Astellas Pharma US INC | $104.69 | 2024-2025 | Veozah |
| Organon LLC | $103.56 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $73.83 | 2023-2025 | Slynd |
| Evofem Biosciences, INC. | $72.08 | 2022-2025 | Phexxi, Solosec, Phexx |
| Myovant Sciences INC. | $66.07 | 2022 | |
| Hologic Sales and Service, LLC | $63.47 | 2023-2024 | Aptima |
| Sumitomo Pharma America, INC. | $51.22 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $43.59 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $38.85 | 2022 | |
| Abbvie INC. | $37.29 | 2022-2023 | |
| Exact Sciences Corporation | $36.52 | 2025 | The Cologuard Plus Collection Kit |
| Biogen, INC. | $26.82 | 2025 | Zurzuvae |
| Smith+Nephew, INC. | $21.38 | 2025 | Stravix Pl |
| Scynexis, INC. | $21.15 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.66 | 2024 | Airsupra |
| Medtronic, INC. | $20.06 | 2025 | Truclear |
| Sage Therapeutics, LLC | $19.43 | 2024 | |
| Mayne Pharma Commercial LLC | $18.55 | 2023 | |
| Asensus Surgical, INC. | $17.34 | 2023 | Senhance |
| Lilly USA, LLC | $16.59 | 2024 | |
| Teleflex LLC | $16.56 | 2025 | Weck |
| Merck Sharp & Dohme LLC | $16.23 | 2025 | Enflonsia, Capvaxive, Gardasil 9 |
| Becton, Dickinson and Company | $15.24 | 2025 | Bd Onclarity |
| Bayer Healthcare Pharmaceuticals INC. | $14.90 | 2024 | |
| Amgen INC. | $14.49 | 2022 | |
| Millicent US INC | $14.10 | 2024 | Intrarosa, Femring |
| Currax Pharmaceuticals LLC | $14.00 | 2024 | Onzetra Xsail, Contrave |
| Minerva Surgical, INC | $13.80 | 2022 | |
| Coopersurgical, INC. | $11.69 | 2022 | |
| Aspira Women'S Health INC | $11.34 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Knapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.